bioRxivGenomicsPreprint
Process-specific somatic mutation distributions vary with three-dimensional genome structure
Kadir Caner AkdemiriD, Victoria T. Le, Sarah KillcoyneiD, Devin A. KingiD, Ya-Ping Li, Yanyan Tian, Akira Inoue, Samirkumar B. AminiD, Frederick Scott RobinsoniD, Rafael E. HerreraiD, Erica J. LynniD, Kin ChaniD, Sahil SethiD, Leszek J. KlimczakiD, Moritz GerstungiD, Dmitry A. GordeniniD, John O’BrieniD, Lei LiiD, Roel G.W. VerhaakiD, Peter J. CampbelliD, Rebecca Claire FitzgeraldiD, Ashby J. MorrisoniD, Jesse R. DixoniD, P. Andrew FutrealiD
Abstract
Somatic mutations arise during the life history of a cell. Mutations occurring in cancer driver genes may ultimately lead to the development of clinically detectable disease. Nascent cancer lineages continue to acquire somatic mutations throughout the neoplastic process and during cancer evolution (Martincorena and Campbell, 2015). Extrinsic and endogenous mutagenic factors contribute to the accumulation of these somatic mutations (Zhang and Pellman, 2015). Understanding the underlying factors generating somatic mutations is crucial for developing potential preventive, therapeutic and clinical decisions. Earlier studies have revealed that DNA replication timing (Stamatoyannopoulos et al., 2009) and chromatin modifications (Schuster-Bockler and Lehner, 2012) are associated with variations in mutational density. What is unclear from these early studies, however, is whether all extrinsic and exogenous factors that drive somatic mutational processes share a similar relationship with chromatin state and structure. In order to understand the interplay between spatial genome organization and specific individual mutational processes, we report here a study of 3000 tumor-normal pair whole genome datasets from more than 40 different human cancer types. Our analyses revealed that different mutational processes lead to distinct somatic mutation distributions between chromatin folding domains. APOBEC- or MSI-related mutations are enriched in transcriptionally-active domains while mutations occurring due to tobacco-smoke, ultraviolet (UV) light exposure or a signature of unknown aetiology (signature 17) enrich predominantly in transcriptionally-inactive domains. Active mutational processes dictate the mutation distributions in cancer genomes, and we show that mutational distributions shift during cancer evolution upon mutational processes switch. Moreover, a dramatic instance of extreme chromatin structure in humans, that of the unique folding pattern of the inactive X-chromosome leads to distinct somatic mutation distribution on X chromosome in females compared to males in various cancer types. Overall, the interplay between three-dimensional genome organization and active mutational processes has a substantial influence on the large-scale mutation rate variations observed in human cancer.
- organism: human
- assay: whole-genome sequencing
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: variant calling
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers
Marina Salvadores, Fran Supek·Nature CancerPeer-reviewed·Jan 10, 2024
- Chromatin accessibility of primary human cancers ties regional mutational processes with tissues of origin
Oliver Ocsenas, Jüri Reimand·PLoS Computational BiologyPeer-reviewed·Aug 10, 2022
- Tumor mutational landscape is a record of the pre-malignant state
Kirsten Kübler, Rosa Karlić, … Gad A. Getz·bioRxiv·Jan 11, 2019
- Topography of mutational signatures in human cancer
B. Otlu-Saritas, M. Diaz-Gay, … L. B. Alexandrov·bioRxiv·May 29, 2022
- Chromatin marks govern mutation landscape of cancer at early stage of progression
Kyungsik Ha, Hong-Gee Kim, Hwajin Lee·bioRxiv·Sep 12, 2016
- Regional mutational signature activities in cancer genomes
C. Timmons, Q. Morris, C. F. Harrigan·bioRxiv·Jan 23, 2022